Black Diamond Therapeutics
Eric Zhao currently serves as the Executive Director and Head of Field and Patient Engagement in Oncology at Black Diamond Therapeutics since August 2022. Prior to this role, Eric held significant positions in oncology at SpringWorks Therapeutics as a Senior Medical Science Liaison and at Amgen as a Senior Regional Medical Liaison, among other titles. Eric's career also includes experience at Teva Pharmaceuticals, Daiichi Sankyo, and various internships in regulatory affairs and pharmacy, including positions at Eli Lilly and Abbott Laboratories. Eric earned a Doctor of Pharmacy (PharmD) with High Distinction from the University of Michigan.
This person is not in any teams
This person is not in any offices
Black Diamond Therapeutics
3 followers
Black Diamond Therapeutics is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.